This prospective, randomized study,control study aims to compare the analgesic effect,opioids consumption,quality of recovery,length of hospital stay and incidence of chronic pain,et al. single-injection TPVB +continuous(pulsatile infusion) TPVB and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal incision.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Enrollment
76
Inject local anesthetics in the T8 paravertebral space followed with catheter insertion and continuous local infusion.
The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scanning
Xulei CUI
Beijing, Beijing Municipality, China
cumulative morphine consumption
Time frame: within 48 postoperative hours
The pain scores determined by the numeric rating scale (NRS, 0-10)
Time frame: At 0, 2,4, 8, 12, 24 ,48,72hours and 7day after the surgery
nausea and vomiting score
Time frame: At 0, 2,4, 8, 12, 24 and 48hours after the surgery
pruritus score
Time frame: At 0, 2,4, 8, 12, 24 and 48hours after the surgery
ambulation time
Time frame: within the 7 days after surgery
time of recovery of bowl movement
Time frame: within the 7 days after surgery
Postoperative hospital length of stay
Time frame: Up to 4 weeks
patient satisfaction with anesthesia
use the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia
Time frame: 48 hours after surgery
data collection of chronic pain
Patients undergo a telephone interview with a questionnaire at 3, 6 and 12 months after surgery, the incidence and severity of chronic pain is recorded.
Time frame: at 3,6,12 months after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
* 2mg/kg ropivacaine in saline with 1:200,000 adrenaline, 25ml in total * given immediately after the correct position of the tip of the needle has been confirmed
* 0.2% ropivacaine, pulse dosadge: 0.125ml/kg/pulse, 1pulse/h at a rate of 6ml/minutes * given through the catheter inserted in the T8 paravertebral space following the single dose
bolus: 2mg, lock time: 10min, 1h limitation: 8mg